Betaxolol Market: : Size, Growth, Regional Analysis, And Market Analysis

Betaxolol:

Betaxolol is a beta-adrenergic receptor inhibitor and racemic combination used to treat chronic open-angle glaucoma and ocular hypertension. It was initially approved as an oral tablet by the US Food and Drug Administration (FDA) in 1989.


Market Growth:

The global Betaxolol Market is growing in tandem with an increase in the prevalence of hypertension worldwide. Hypertension is a serious medical condition that increases the chance of developing other ailments. In 2019, an estimated 26% of the world's population suffered from hypertension. By 2025, the prevalence is anticipated to rise to 29%, owing to an ageing population, increased job stress, and bad eating habits such as high salt, low potassium, obesity, alcohol use, physical inactivity, and an unhealthy diet.


Hypertension affects 42.7 percent of people over 60 years old, which is much higher. All of these factors will increase demand for Betaxolol. Other drugs, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), diuretics, Beta-blockers, and Alpha-blockers, limit the market growth. The rise in glaucoma cases around the world is a major element driving the global betaxolol market forward. Glaucoma is the primary cause of irreversible blindness globally, according to the Glaucoma Research Foundation. Even after receiving effective therapy, about 10% of glaucoma patients have vision loss.


Regional Analysis:

North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa are the continents represented. North America dominates the market and controls the majority of the market share. This is due to the region's population's high prevalence of diabetes and eye-related illnesses. According to the National Federation of the Blind, around 1.3 million individuals were legally blind in the United States in 2014. Over 75,000 people are predicted to be blind or visually impaired in the United States each year.


Key Players:

Novartis AG, Genix Pharma (Pvt.) Ltd., East-West Pharma, Hetero Healthcare Ltd. (GenX), Cadila Pharmaceuticals Ltd., Jawa Pharmaceuticals (INDIA) Pvt. Ltd., DAL Medical Services Company Ltd, Sentiss Pharma Pvt. Ltd., Humanwell Healthcare Group, and PuraCap Pharmaceutical LLC are among the market players in the betaxolol market.


Comments

Popular posts from this blog

Significance of EHealth Software And Services

The OKR Software Market Is Estimated To Increase At A CAGR Of 12.60 Percent During The Forecast Period

Broadcast Switchers Market Report | the Demand for the Market Will Drastically Increase in the Future